WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992003579) AN AUGMENTED WESTERN BLOT FORMAT AND IMMUNOASSAY FOR DETECTION OF VIRAL ANTIBODIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/003579    International Application No.:    PCT/US1991/005831
Publication Date: 05.03.1992 International Filing Date: 14.08.1991
Chapter 2 Demand Filed:    16.03.1992    
IPC:
C07K 14/16 (2006.01), C07K 16/42 (2006.01), G01N 33/569 (2006.01)
Applicants: DIAGNOSTIC BIOTECHNOLOGY, INC. [US/US]; 9124 Wandering Trail Drive, Potomac, MD 20854 (US)
Inventors: CHAN, Lily; (SG).
SUM, Yoke, Wah; (SG).
YIN, May, Fong; (SG).
LIM, Lee, Fang; (SG)
Agent: DEHLINGER, Peter, J.; Law Offices of Peter J. Dehlinger, P.O. Box 60850, Palo Alto, CA 94306 (US)
Priority Data:
568,144 16.08.1990 US
Title (EN) AN AUGMENTED WESTERN BLOT FORMAT AND IMMUNOASSAY FOR DETECTION OF VIRAL ANTIBODIES
(FR) FORMAT DE CHARGE DE TYPE WESTERN AUGMENTE ET IMMUNOANALYSE DE DETECTION D'ANTICORPS VIRAUX
Abstract: front page image
(EN)A method for producing an improved solid phase antigenic reagent useful in an immunoassay for detecting antibodies specific for a virus, such as the human immunodeficiency virus, is disclosed which comprises the addition to a natural viral lysate a synthetic or recombinant viral protein or peptide. Also provided is an improved immunoassay utilizing the solid phase antigenic reagent.
(FR)Procédé de production d'un réactif antigénique en phase solide amélioré utile dans une immunoanalyse permettant de détecter des anticorps spécifiques contre un virus, tel que le virus d'immunodéficience humaine. Ce procédé comprend l'addition à un lysat viral naturel d'un peptide ou d'une protéine virale synthétique ou recombinante. Une immunoanalyse améliorée utilisant le réactif antigénique en phase solide est également décrite.
Designated States: AT, AU, BB, BG, BR, CA, CH, CS, DE, DK, ES, FI, GB, HU, JP, KP, KR, LK, LU, MC, MG, MN, MW, NL, NO, PL, RO, SD, SE, SU.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)